SNP Therapeutics has a U.S. PATENT on a Genetic Test, Algorithm and Nutrition Treatment for Male Infertility. This Genetic test identifies men who are at high risk for sperm motility due to critical misspellings in genes associated with spermatic ATP function. Men with these SNPs have sperm motility that can be treated with a patented nutritional formulation.
It is estimated that 8-12% of couples worldwide have infertility issues and that 50% of infertility in couples worldwide is due to male factor issues. The Algorithm developed from a study of 246 men provides a genetic test and treatment that can provide hope to millions of couples worldwide.